A case-control study to identify molecular risk factors for local recurrence in young breast cancer patients

Breast conserving therapy (BCT), consisting of breast conserving surgery followed by whole breast irradiation is the standard treatment for early stage breast cancer. In the EORTC boost-no boost trial a boost of 16 Gy to the primary tumor bed reduced the LR rate from 10.2 to 6.2% (p

Source: Radiotherapy and Oncology - November 24, 2020 Category: Radiology Authors: Sophie CJ Bosma, Marlous Hoogstraat, Erik van Werkhoven, Michiel de Maaker, Femke van der Leij, Paula HM Elkhuizen, Alain Fourquet, Philip Poortmans, Liesbeth J Boersma, Harry Bartelink, Marc J van de Vijver Tags: Original Article Source Type: research